Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pfaller

Showing results (61-70 of 542) with videos related to

Pageof 55
Sort By:
The Journal of Antimicrobial Chemotherapy|August 1, 1987
In-vitro activity of paldimycin against methicillin-resistant and susceptible isolates of Staphylococcus aureus and S. epidermidisM A Pfaller, M Bale, M Barrett
Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society for Human and Animal Mycology|April 1, 1988
Polyamine depletion and growth inhibition in Candida albicans and Candida tropicalis by alpha-difluoromethylornithine and cyclohexylamineM A Pfaller, J Riley, T Gerarden
Journal of Clinical Microbiology|January 1, 1996
Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrataM A Pfaller, A Houston, S Coffmann
Mycopathologia|October 1, 1990
Polyamine depletion and growth inhibition of Cryptococcus neoformans by alpha-difluoromethylornithine and cyclohexylamineM A Pfaller, J Riley, T Gerarden
Mycopathologia|April 1, 1987
Growth inhibition of pathogenic yeast isolates by alpha-difluoromethylornithine: an inhibition of ornithine decarboxylaseM A Pfaller, T Gerarden, J Riley
Antimicrobial Agents and Chemotherapy|April 1, 1997
In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agentsM A Pfaller, S A Messer, S Coffman
Diagnostic Microbiology and Infectious Disease|March 15, 2001
Activity and spectrum of BMS 284756, a new des-F (6) quinolone, tested against strains of ciprofloxacin-resistant Gram-positive cocciR N Jones, M A Pfaller, M Stilwell, et al.
Journal of Clinical Microbiology|December 1, 1996
In vitro susceptibility testing and DNA typing of Saccharomyces cerevisiae clinical isolatesL Zerva, R J Hollis, M A Pfaller
Antimicrobial Agents and Chemotherapy|February 1, 1997
Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiaeM A Pfaller, S Messer, R N Jones
Infectious Disease Clinics of North America|June 1, 1997
Role of molecular epidemiology in infection controlS Weber, M A Pfaller, L A Herwaldt
Pageof 55

Showing results (61-70 of 542) with videos related to

Sort By:
Pageof 55
The Journal of Antimicrobial Chemotherapy|August 1, 1987
In-vitro activity of paldimycin against methicillin-resistant and susceptible isolates of Staphylococcus aureus and S. epidermidisM A Pfaller, M Bale, M Barrett
Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society for Human and Animal Mycology|April 1, 1988
Polyamine depletion and growth inhibition in Candida albicans and Candida tropicalis by alpha-difluoromethylornithine and cyclohexylamineM A Pfaller, J Riley, T Gerarden
Journal of Clinical Microbiology|January 1, 1996
Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrataM A Pfaller, A Houston, S Coffmann
Mycopathologia|October 1, 1990
Polyamine depletion and growth inhibition of Cryptococcus neoformans by alpha-difluoromethylornithine and cyclohexylamineM A Pfaller, J Riley, T Gerarden
Mycopathologia|April 1, 1987
Growth inhibition of pathogenic yeast isolates by alpha-difluoromethylornithine: an inhibition of ornithine decarboxylaseM A Pfaller, T Gerarden, J Riley
Antimicrobial Agents and Chemotherapy|April 1, 1997
In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agentsM A Pfaller, S A Messer, S Coffman
Diagnostic Microbiology and Infectious Disease|March 15, 2001
Activity and spectrum of BMS 284756, a new des-F (6) quinolone, tested against strains of ciprofloxacin-resistant Gram-positive cocciR N Jones, M A Pfaller, M Stilwell, et al.
Journal of Clinical Microbiology|December 1, 1996
In vitro susceptibility testing and DNA typing of Saccharomyces cerevisiae clinical isolatesL Zerva, R J Hollis, M A Pfaller
Antimicrobial Agents and Chemotherapy|February 1, 1997
Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiaeM A Pfaller, S Messer, R N Jones
Infectious Disease Clinics of North America|June 1, 1997
Role of molecular epidemiology in infection controlS Weber, M A Pfaller, L A Herwaldt
Pageof 55